Table 1.
General characteristics and prevalence of selected diseases among SCOPE study participants (N = 2252) and their distribution across physical performance status
| All patients N = 2252 |
SPPB score | P | |||
|---|---|---|---|---|---|
| 9–12 N = 1391 |
5–8 N = 614 |
0–4 N = 247 |
|||
| Age, years | 80.3 ± 4.1 | 79.6 ± 3.7 | 81.2 ± 4.4 | 82.4 ± 4.7 | < 0.001 |
| Sex, women | 1254 (55.7) | 698 (50.2) | 381 (62.1) | 175 (70.9) | < 0.001 |
| Hypertension | 1729 (76.8) | 997 (71.7) | 509 (82.9) | 223 (90.3) | < 0.001 |
| CKD | 1487 (66.0) | 871 (62.6) | 415 (67.6) | 201 (81.4) | < 0.001 |
| Vision impairment | 1299 (57.7) | 758 (54.5) | 370 (60.3) | 171 (69.2) | < 0.001 |
| Hearing impairment | 1165 (51.7) | 661 (47.5) | 348 (56.7) | 156 (63.2) | < 0.001 |
| Osteoporosis | 687 (30.5) | 324 (23.3) | 243 (39.6) | 120 (48.6) | < 0.001 |
| Diabetes | 566 (25.1) | 280 (20.1) | 188 (30.6) | 98 (39.7) | < 0.001 |
| Anemia | 476 (21.1) | 228 (16.4) | 150 (24.4) | 98 (39.7) | < 0.001 |
| Cancer | 388 (17.2) | 234 (16.8) | 104 (16.9) | 50 (20.2) | 0.413 |
| CHF | 373 (16.6) | 187 (13.4) | 119 (19.4) | 67 (27.1) | < 0.001 |
| Atrial fibrillation | 344 (15.3) | 159 (11.4) | 116 (18.9) | 69 (27.9) | < 0.001 |
| Depression | 316 (14.0) | 134 (9.6) | 113 (18.4) | 69 (27.9) | < 0.001 |
| COPD | 266 (11.8) | 149 (10.7) | 86 (14) | 31 (12.6) | 0.101 |
| Myocardial infarction | 217 (9.6) | 112 (8.1) | 65 (10.6) | 40 (16.2) | < 0.001 |
| TIA | 196 (8.7) | 104 (7.5) | 64 (10.4) | 28 (11.3) | 0.029 |
| Cognitive impairment | 165 (7.3) | 71 (5.1) | 59 (9.6) | 35 (14.2) | < 0.001 |
| Angina | 133 (5.9) | 72 (5.2) | 39 (6.4) | 22 (8.9) | 0.062 |
| Stroke | 131 (5.8) | 59 (4.2) | 45 (7.3) | 27 (10.9) | < 0.001 |
| Asthma | 124 (5.5) | 73 (5.2) | 30 (4.9) | 21 (8.5) | 0.087 |
| Hip fracture | 111 (4.9) | 32 (2.3) | 51 (8.3) | 28 (11.3) | < 0.001 |
| Parkinson | 45 (2.0) | 11 (0.8) | 17 (2.8) | 17 (6.9) | < 0.001 |
Data are mean ± SD or number of cases (percentage)